Donald F. Chute

1.5k total citations
24 papers, 894 citations indexed

About

Donald F. Chute is a scholar working on Hepatology, Transplantation and Oncology. According to data from OpenAlex, Donald F. Chute has authored 24 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 8 papers in Transplantation and 7 papers in Oncology. Recurrent topics in Donald F. Chute's work include Hepatitis C virus research (11 papers), Renal Transplantation Outcomes and Treatments (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Donald F. Chute is often cited by papers focused on Hepatitis C virus research (11 papers), Renal Transplantation Outcomes and Treatments (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Donald F. Chute collaborates with scholars based in United States and Thailand. Donald F. Chute's co-authors include Meghan E. Sise, Kerry L. Reynolds, Ryan J. Sullivan, Meghan J. Mooradian, Raymond T. Chung, Justine V. Cohen, Nathan F. Clement, Divyanshu Dubey, Donald P. Lawrence and William S. David and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Donald F. Chute

23 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald F. Chute United States 13 421 266 261 203 124 24 894
Annette Jappe Switzerland 11 227 0.5× 354 1.3× 242 0.9× 193 1.0× 314 2.5× 14 1.1k
Philipp Ivanyi Germany 18 440 1.0× 23 0.1× 468 1.8× 94 0.5× 32 0.3× 97 943
Salem Almaani United States 13 88 0.2× 138 0.5× 167 0.6× 76 0.4× 22 0.2× 36 1.3k
Robert Winkler United States 16 895 2.1× 118 0.4× 140 0.5× 823 4.1× 11 0.1× 59 1.3k
Akinari Sekine Japan 12 112 0.3× 82 0.3× 154 0.6× 88 0.4× 15 0.1× 113 667
Takafumi Kumamoto Japan 17 600 1.4× 473 1.8× 297 1.1× 149 0.7× 34 0.3× 78 1.1k
Jean Tayar United States 10 453 1.1× 13 0.0× 138 0.5× 93 0.5× 17 0.1× 30 846
Tetsunosuke Shimizu Japan 19 436 1.0× 541 2.0× 284 1.1× 188 0.9× 56 0.5× 70 1.3k
Ketki Tendulkar United States 13 345 0.8× 17 0.1× 265 1.0× 76 0.4× 21 0.2× 22 645
Allen R. Hendricks United States 8 79 0.2× 62 0.2× 72 0.3× 81 0.4× 14 0.1× 16 913

Countries citing papers authored by Donald F. Chute

Since Specialization
Citations

This map shows the geographic impact of Donald F. Chute's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald F. Chute with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald F. Chute more than expected).

Fields of papers citing papers by Donald F. Chute

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald F. Chute. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald F. Chute. The network helps show where Donald F. Chute may publish in the future.

Co-authorship network of co-authors of Donald F. Chute

This figure shows the co-authorship network connecting the top 25 collaborators of Donald F. Chute. A scholar is included among the top collaborators of Donald F. Chute based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald F. Chute. Donald F. Chute is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seethapathy, Harish, Meghan Lee, Ian A. Strohbehn, et al.. (2020). Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib. Nephrology Dialysis Transplantation. 37(3). 507–514. 10 indexed citations
2.
Seethapathy, Harish, Donald F. Chute, Ian A. Strohbehn, et al.. (2020). Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma. Kidney Medicine. 2(3). 373–375. 7 indexed citations
3.
Lee, Meghan, Harish Seethapathy, Orhan Efe, et al.. (2020). Dabrafenib-Induced Acute Interstitial Nephritis (AIN) and AKI in Patients with Cancer. Journal of the American Society of Nephrology. 31(10S). 664–664.
4.
Seethapathy, Harish, Sophia Zhao, Ian A. Strohbehn, et al.. (2020). Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors. Kidney International Reports. 5(10). 1700–1705. 43 indexed citations
5.
Sise, Meghan E., Ian A. Strohbehn, Donald F. Chute, et al.. (2020). Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C–Viremic Donor to Uninfected Recipient Kidney Transplantation. Kidney International Reports. 5(4). 459–467. 10 indexed citations
6.
Dubey, Divyanshu, William S. David, Kerry L. Reynolds, et al.. (2020). Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum. Annals of Neurology. 87(5). 659–669. 151 indexed citations
7.
Sise, Meghan E., Ian A. Strohbehn, Donald F. Chute, et al.. (2020). Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus. Hepatology Communications. 4(8). 1206–1217. 3 indexed citations
8.
Seethapathy, Harish, Donald F. Chute, Meghan Lee, et al.. (2020). Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors. Nephrology Dialysis Transplantation. 36(12). 2241–2247. 39 indexed citations
9.
Durbin, Sienna, Meghan J. Mooradian, Florian J. Fintelmann, et al.. (2020). Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitis. Journal for ImmunoTherapy of Cancer. 8(2). e001329–e001329. 16 indexed citations
10.
Dubey, Divyanshu, William David, Kerry L. Reynolds, et al.. (2019). Immune checkpoint inhibitor related neurologic adverse events: clinical spectrum, management and outcomes (S21.003). Neurology. 92(15_supplement). 2 indexed citations
11.
Seethapathy, Harish, Sophia Zhao, Donald F. Chute, et al.. (2019). The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors. Clinical Journal of the American Society of Nephrology. 14(12). 1692–1700. 205 indexed citations
12.
Dubey, Divyanshu, William S. David, Anthony A. Amato, et al.. (2019). Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies. Neurology. 93(11). 111 indexed citations
13.
Sise, Meghan E., Donald F. Chute, Yaa Oppong, et al.. (2019). Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease. Kidney International. 97(1). 193–201. 44 indexed citations
14.
Chute, Donald F. & Meghan E. Sise. (2018). Effect of the Opioid Crisis on the Donor Pool for Kidney Transplantation: An Analysis of National Kidney Deceased Donor Trends from 2010–2016. American Journal of Nephrology. 47(2). 84–93. 24 indexed citations
15.
Chute, Donald F., Raymond T. Chung, & Meghan E. Sise. (2018). Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient. Kidney International. 93(3). 560–567. 41 indexed citations
16.
Sise, Meghan E., Donald F. Chute, Jenna Gustafson, et al.. (2018). Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients. Hemodialysis International. 22(S1). S71–S80. 10 indexed citations
17.
Chute, Donald F., et al.. (2017). When and how can nephrologists treat hepatitis C virus infection in dialysis patients?. Seminars in Dialysis. 31(1). 26–36. 8 indexed citations
18.
Sise, Meghan E., Guillermo Ortiz, Gregory L. Hundemer, et al.. (2017). Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD. Clinical Journal of the American Society of Nephrology. 12(10). 1615–1623. 57 indexed citations
19.
Sise, Meghan E., Jessica Wisocky, Ivy A. Rosales, et al.. (2016). Lupus-Like Immune Complex-Mediated Glomerulonephritis in Patients With Hepatitis C Virus Infection Treated With Oral, Interferon-Free, Direct-Acting Antiviral Therapy. Kidney International Reports. 1(3). 135–143. 23 indexed citations
20.
Lin, Ming, Meghan E. Sise, Martha Pavlakis, et al.. (2016). Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. PLoS ONE. 11(7). e0158431–e0158431. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annette Jappe Breakdown of academic impact, for papers by Philipp Ivanyi Breakdown of academic impact, for papers by Salem Almaani Breakdown of academic impact, for papers by Robert Winkler Breakdown of academic impact, for papers by Akinari Sekine Breakdown of academic impact, for papers by Takafumi Kumamoto Breakdown of academic impact, for papers by Jean Tayar Breakdown of academic impact, for papers by Tetsunosuke Shimizu Breakdown of academic impact, for papers by Ketki Tendulkar Breakdown of academic impact, for papers by Allen R. Hendricks
Rankless by CCL
2026